title: Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy.
abstract: OBJECTIVE
  To evaluate optical coherence tomography (OCT) thickness of the macula in people with diabetes but minimal or no retinopathy and to compare these findings with published normative data in the literature from subjects reported to have no retinal disease.
  
  
  METHODS
  Cross-sectional study.
  
  
  METHODS
  In a multicenter community- and university-based practices setting, 97 subjects with diabetes with no or minimal diabetic retinopathy and no central retinal thickening on clinical examination and a center point thickness of 225 microm or less on OCT (Stratus OCT; Carl Zeiss Meditec, Dublin, California, USA) were recruited. Electronic Early Treatment of Diabetic Retinopathy Study best-corrected visual acuity, seven-field stereoscopic color fundus photographs, and Stratus OCT fast macular scan were noted. Main outcome measures were central subfield (CSF) thickness measured on Stratus OCT.
  
  
  RESULTS
  On average, CSF thickness was 201 +/- 22 microm. CSF thickness was significantly greater in retinas from men than retinas from women (mean +/- standard deviation, 209 +/- 18 microm vs 194 +/- 23 microm; P < .001). After adjusting for gender, no additional factors were found to be associated significantly with CSF thickness (P > .10).
  
  
  CONCLUSIONS
  CSF thicknesses on Stratus OCT in people with diabetes and minimal or no retinopathy are similar to thicknesses reported from a normative database of people without diabetes. CSF thickness is greater in men than in women, consistent with many, but not all, previous reports. Studies involving comparisons of retinal thickness with expected norms should consider different mean values for women and men.
authors.affiliation: Jaeb Center for Health Research, Tampa, FL 33647, USA.
authors.forename: Neil M
authors.initials: NM
authors.lastname: Bressler
authors.forename: Allison R
authors.initials: AR
authors.lastname: Edwards
authors.forename: Andrew N
authors.initials: AN
authors.lastname: Antoszyk
authors.forename: Roy W
authors.initials: RW
authors.lastname: Beck
authors.forename: David J
authors.initials: DJ
authors.lastname: Browning
authors.forename: Antonio P
authors.initials: AP
authors.lastname: Ciardella
authors.forename: Ronald P
authors.initials: RP
authors.lastname: Danis
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Elman
authors.forename: Scott M
authors.initials: SM
authors.lastname: Friedman
authors.forename: Adam R
authors.initials: AR
authors.lastname: Glassman
authors.forename: Jeffrey G
authors.initials: JG
authors.lastname: Gross
authors.forename: Helen K
authors.initials: HK
authors.lastname: Li
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Murtha
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Stone
authors.forename: Jennifer K
authors.initials: JK
authors.lastname: Sun
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003930:Diabetic Retinopathy / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D012160:Retina / Q000473:pathology*; D041623:Tomography, Optical Coherence / Q000379:methods*; D014792:Visual Acuity